Skip to main content

ADHD Archives

Defective transporter linked to autism

Jul. 24, 2019—A first-of-its-kind mouse model may help reveal mechanistic underpinnings for the altered behaviors of autism spectrum disorder.

Read more


‘Darting’ mice may hold clues to ADHD, autism and bipolar disorder

Oct. 23, 2014—The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders.

Read more


U.S. Senate hearing explores ADHD treatment concerns

Feb. 27, 2014—William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and Health Policy, testified Tuesday before the U.S. Senate Health, Education, Labor and Pensions (HELP) committee regarding psychotropic medications and treatments for Attention Deficit Hyperactivity Disorder (ADHD).

Read more


Neurotransmitter’s role in bone balance

Nov. 7, 2013—Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling.

Read more


Transporter linked to autism risk

Sep. 19, 2013—Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD).

Read more


Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk

Aug. 22, 2013—Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.

Read more


New clue to ADHD

May. 15, 2012—A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.

Read more


Minds wide open: Neuroscience at Vanderbilt

Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.

Read more


Vanderbilt study finds no heart risk in ADHD medications

Nov. 2, 2011—Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.

Read more


Recent Stories from VUMC News and Communications Publications

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer.  Don’t hesitate. Do it.

Momentum

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer. Don’t hesitate. Do it.

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

Vanderbilt Medicine

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

VUMC campus

VUMC campus

Vanderbilt University School of Medicine entrance

Vanderbilt University School of Medicine entrance

more